Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 37.74
-0.343 %
$ 2.08 B
Market Cap
35.27
P/E
SUPN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SUPN - Supernus Pharmaceuticals, Inc.
-398 M
LAST VALUE
-74.66%
2 YEAR CAGR
-15.52%
5 YEAR CAGR
-22.06%
10 YEAR CAGR